INTRODUCTION
Differentiated somatic cells exhibit distinct functions and behaviors that are specified by their developmental programs. In the past two decades, tremendous progress has been achieved in elucidating genetic and epigenetic mechanisms underlying differentiation of specialized cell lineages and organ development. However, little is known about how, and to what degree, the differentiated cells maintain their fate or lose their identity in response to changing environment or upon cell division, the two conditions that may disturb the inheritance of lineage-specifying factors (Sá nchez Alvarado and Yamanaka, 2014) . Consequently, factors that affect identity and function of a given cell type and molecular basis of their robustness upon environmental perturbations and its biological significance remain poorly understood.
The adaptive immune system with its somatic diversification of antigen receptors of essentially unlimited specificity affords vertebrates with an effective means of defense against previously encountered and new infectious agents. Potentially deleterious self-reactivity and ''collateral'' damage resulting in an impairment or loss of tissue function has been a tradeoff for the emergence of adaptive immunity. Central to limiting excessive immune responses and associated inflammation is their suppression mediated by regulatory T (Treg) cells, a subset of CD4 + T cells expressing X-chromosome-encoded transcription factor Foxp3. Foxp3 is specifically expressed in Treg cells and plays a key role in their differentiation and function . During the differentiation of Treg cells, Foxp3 is induced in response to TCR and IL-2 signaling Sekiya et al., 2013) , and Foxp3 protein expression is required for Treg cell function (Gavin et al., 2007; Lin et al., 2007) . In addition to conferring cellular identity and functional competence during differentiation of Treg cells, Foxp3 plays an essential role in their maintenance because deletion of a conditional Foxp3 allele in differentiated Treg cells results in a loss of their function (Williams and Rudensky, 2007) . Genetic fate mapping using inducible and constitutive Cre revealed heritable and stable Foxp3 expression in the Treg cell population in unchallenged mice as well as in the context of infection and autoimmune inflammation (Miyao et al., 2012; Rubtsov et al., 2010) . In contrast, almost half of newly generated extrathymic Treg cells lose Foxp3 expression . Thus, Treg cells represent a distinct cell lineage and Foxp3 is its late acting specification factor whose stable expression is a requisite for preserving Treg cell identity and functional integrity. These findings also implied the existence of a distinct mechanism that ensures Treg cell lineage stability. A conserved intronic regulatory element CNS2 is required for the maintenance of Foxp3 expression in the progeny of dividing Treg cells but does not affect Foxp3 induction and its amount on a per cell basis (Zheng et al., 2010) . CNS2 can be bound by numerous transcription factors, including STAT5, STAT3, and Foxp3, but how these factors regulate Foxp3 expression during cell division remains unknown (Samstein et al., 2012; Xu et al., 2010; Yao et al., 2007; Zheng et al., 2010) . CNS2 contains a stretch of CpG bases that are fully methylated in precursor cells but undergo demethylation upon Foxp3 expression (Floess et al., 2007; Kim and Leonard, 2007; Polansky et al., 2008; Toker et al., 2013) . Previous studies suggested a correlation between the methylated state of CNS2 and unstable Foxp3 expression (Bailey-Bucktrout et al., 2013; Floess et al., 2007; Polansky et al., 2008) . Genetic targeting of the pivotal DNA methyltransferase Dnmt1 or pharmacological inhibition of DNA methyltransferase activity results in a sharp increase in Foxp3 induction efficiency upon activation of naive T cells (Floess et al., 2007; Josefowicz et al., 2009; Kim and Leonard, 2007) .
Despite a considerable body of work, the biological role of CNS2 in the regulation of Foxp3 expression has not been elucidated, and a mechanistic understanding of CNS2 function and its biological role are lacking. Here, we demonstrated that CNS2 serves as a sensor of IL-2/STAT5 signaling that prevents Treg conversion into effector T cells upon exposure to proinflammatory cytokines. CNS2 conferred stable inheritance of Foxp3 expression at limiting amounts of IL-2, which was of particular significance for control of chronic inflammation in a wide range of biological contexts.
RESULTS

Heritability of Foxp3 Expression and CpG Methylation in the Foxp3
Locus Lymphopenic or proinflammatory conditions are associated with the instability of Treg cells; however, its cause and consequences have not been examined (Bailey-Bucktrout et al., 2013; Komatsu et al., 2013) . We observed accumulation of Foxp3 À cells (exTreg) upon Treg cell division in response to TCR stimulation in vitro. This was unlikely due to the contamination with effector T cells because the starting population contained 99.8% Foxp3 + cells ( Figure 1A and data not shown). To demonstrate that the loss of Foxp3 was due to division of Treg cells, we blocked cell-cycle progression using pharmacological inhibitors targeting different stages of the cell cycle. The cell-cycle blockade fully rescued Foxp3 expression ( Figure 1B ), suggesting that its loss was indeed cell-cycle dependent.
To investigate whether CpG methylation (mCpG) plays a role in the regulation of heritable Foxp3 expression, we examined the mCpG levels across the Foxp3 locus by bisulfite sequencing in resting and dividing Treg cells as compared to non-Treg cells that do not express Foxp3 or ''exTreg'' cells that have lost Foxp3 expression either in vitro or in vivo. In agreement with previous reports, À1.5 kb, CNS2, and exon À1 were methylated in non-Treg cells and were largely or fully demethylated in Treg cells (Floess et al., 2007; Ohkura et al., 2012) but were remethylated in ''exTreg'' cells that have lost Foxp3 expression either in vivo or in vitro. Importantly, we found a statistically significant increase in mCpG at sites including the À1.5 kb region, CNS2, and exon-1 in dividing Foxp3 + Treg cells ( Figure 1C and Figures S1A-S1C available online). Accordingly, low dose of a DNA methyltransferase inhibitor 5-aza-deoxycytidine (5-aza-dC) prevented loss of Foxp3 expression in Treg cells that underwent a comparable number of cell divisions in the presence or absence of the drug ( Figure S1D ). These findings suggest that CpG methylation might be actively regulated when Treg cells divide and may affect the heritability of Foxp3 expression.
CNS2 Opposes Cell-Cycle-Dependent Loss of Foxp3 Expression in Mature Treg Cells
Studies of Foxp3 DCNS2-gfp mice on a mixed genetic background showed that CNS2 maintains Foxp3 expression in Treg cells (Zheng et al., 2010) . To explore the biological role of CNS2 and the molecular mechanisms of its function in depth, we backcrossed Foxp3 DCNS2-gfp mice onto a C57BL/6 (B6) background (n > 10) and bred them to CNS2-sufficient Foxp3 gfp B6 mice expressing the exact same Foxp3 reporter allele, which serves as an ideal control when segregated into male littermates (Bettini et al., 2012; Darce et al., 2012) . In agreement with previous results on a mixed genetic background (Zheng et al., 2010) Figure S1 .
littermates ( Figure 1D ). Figures 1G, S1E , and S1F) (Rubtsov et al., 2010 (Komatsu et al., 2009; Komatsu et al., 2013) . Such a scenario implied that CNS2 acted in a deterministic manner to maintain Foxp3 expression in a CNS2-dependent Treg cell subset and that CNS2-deficient Treg cells that retained Foxp3 expression after homeostatic expansion were independent of CNS2 for Foxp3 maintenance. Alternatively, it was possible that CNS2 was required for the maintenance of Foxp3 expression in the entire population of dividing Treg cells, but Foxp3 was lost in a stochastic manner. To explore these alternatives, we isolated CNS2-sufficient and -deficient YFP + GFP + Treg cells 7 weeks after the first transfer and transferred them again into T cell-deficient recipients.
Five weeks after secondary transfer, we observed an essentially identical pattern to that of the primary transfer, i.e., $60% loss of Foxp3 expression in the absence of CNS2 ( Figures 1F and 1G ). These results suggested that the loss of Foxp3 expression in mature CNS2-deficient Treg cells was an apparently stochastic event associated with their division.
CNS2 Sustains Heritable Foxp3 Expression in Mature Treg Cells at Limiting Amounts of IL-2
We reasoned that the observed loss of Foxp3 by some Treg cells was either due to the deprivation of a factor(s) that is required for the maintenance of Foxp3 expression and is present in limiting amounts or due to the exposure to a limiting factor(s) that represses Foxp3 expression. IL-2 and STAT5 signaling plays an important role in the regulation of Foxp3 expression (Fontenot et al., 2005; Sakaguchi et al., 1995) . Our recent cell fate mapping studies showed that IL-2 deprivation caused by administration of IL-2-neutralizing antibody results in a loss of Foxp3 expression by only a minor subset ($15%) of YFP-tagged Treg cells (Rubtsov et al., 2010) , though this may be an underestimate because IL-2/STAT5 signaling facilitates Treg cell viability. Thus, IL-2 could be a factor that ''positively'' acts via CNS2 and whose deprivation leads to a pronounced loss of Foxp3 expression in the absence of CNS2. Indeed, CNS2 contains multiple STAT5-binding motifs and can be bound by STAT5 ( Figure S1A ) (Ogawa et al., 2013; Yao et al., 2007) .
Previous studies suggested that Treg cells expressing low amounts of CD25, a subunit of high-affinity IL-2 receptor, are unstable, whereas CD25
high Treg cells faithfully maintain Foxp3
expression. Thus, we sought to examine whether CNS2 is required for the maintenance of Foxp3 expression only in CD25 low or in both CD25 low and CD25 high Treg cells in vivo that are less or more efficient in IL-2 capture and signaling, respectively, as assessed by STAT5 phosphorylation ( Figure S2A ). Upon transfer into lymphopenic host, both CD25 high and CD25 low CNS2-deficient Treg cells showed markedly reduced ability to maintain Foxp3 expression upon cell division, compared to their wild-type counterparts, with CD25 low CNS2-deficient Treg cells exhibiting the most pronounced Foxp3 loss (Figures 2A and S2B) . These results raised the possibility that increased IL-2 signaling may rescue, at least in part, the loss of Foxp3 expression. We directly tested this idea by asking whether provision of high amounts of IL-2 can rescue, at least in part, the loss of Foxp3 in CNS2-deficient Treg cells. Upon TCR engagement, CNS2-deficient Treg cells that divided multiple times (R3, denoted as ''dividing'') largely maintained Foxp3 expression in the presence of high amounts of IL-2, whereas at lower IL-2 levels, a marked reduction in Foxp3 expression was observed on a per cell basis as well as in the percentage of Figure S2 .
subjected to tamoxifen-induced deletion of a ''floxed'' CNS2 allele showed similar sensitivity of heritable Foxp3 expression to low levels of IL-2 ( Figure S2C ). The observed effect was unlikely due to a differential effect of IL-2 on the survival of CNS2-sufficient versus -deficient Treg cells because provision of IL-2 similarly increased the viability of both CNS2-sufficient and -deficient Treg cells in vitro ( Figure 2C ). These results suggested that CNS2 confers the ability of dividing Treg cells to sustain Foxp3 expression upon IL-2 deprivation. These findings raised the possibility that the observed rescue of CNS2 deficiency was due to increased STAT5 activation in response to high amounts of IL-2. Previous studies showed binding of STAT5 to CNS2 (Ogawa et al., 2013; Yao et al., 2007) . In agreement with these data, we found that, within the Foxp3 locus, STAT5 binds predominantly to CNS2 and, to a markedly lesser extent, to the Foxp3 promoter ( Figure 2D ). Interestingly, in the absence of CNS2, binding of STAT5 was noticeably reduced in the Foxp3 promoter and in its À1.5 kb upstream region, suggesting potential interaction between CNS2 and these sites. This observation was consistent with the idea that the partial rescue of the Foxp3 loss associated with CNS2 deficiency in the presence of high amounts of IL-2 was due to heightened STAT5 activation. Figure 2E ).
These results suggested that enhanced IL-2 signaling through activation of STAT5 was able to compensate for the absence of CNS2 and that CNS2 affords Treg cells the ability to effectively sustain Treg identity at low levels of IL-2.
CNS2 Stabilizes Foxp3 Expression in the Presence of Proinflammatory Cytokines
In contrast to the positive role of IL-2 signaling in stabilizing heritable Foxp3 expression, proinflammatory cytokines IL-6, IFNg, IL-12, and IL-4 even in the presence of optimal amounts of IL-2 severely compromised Foxp3 expression in dividing CNS2-deficient Treg cells, whereas in CNS2-sufficient Treg cells, only a fairly small loss of Foxp3 was observed ( Figures  3A and S3A and data not shown). Because in vitro IL-4 exposure caused particularly severe loss of Foxp3 expression in dividing Treg cells, for further investigation of this phenomenon, we focused on IL-4 as an example of proinflammatory cytokines. Notably, the loss of Foxp3 expression induced by IL-4 in CNS2-deficient Treg cells was also observed at the mRNA level and was cell-cycle dependent ( Figures S3A and S3B ).
To explore whether STAT family members activated downstream of proinflammatory cytokine signaling bind to the Foxp3 locus and possibly compete with STAT5, we employed ChIPqPCR to examine STAT6-and STAT5-binding sites at the Foxp3 locus in Treg cells stimulated with IL-2 and IL-4 or with IL-2 alone. We found that, upon combined IL-2 and IL-4 stimulation, STAT6 and STAT5 bind to similar sites-namely, CNS2, the Foxp3 promoter, and its À1.5 kb upstream region ( Figure 3B ). Concomitant with STAT6 binding, STAT5 binding was markedly reduced at the three main sites despite the presence of the same amounts of IL-2 that was used in combination with IL-4 or alone ( Figure 3B ). Of note, IL-2-dependent STAT5 phosphorylation was comparable when Treg cells were stimulated with IL-2 in the presence or absence of IL-4 ( Figure S3C ).
Because STAT5 and STAT6 bind to the same sites within the Foxp3 locus and promote the maintenance and loss of Foxp3 expression, respectively, we asked what protein factors might associate with STAT5 and STAT6 and might contribute to their opposing activity. In light of the observed connection between CpG methylation in the Foxp3 locus, cell division, and the loss of Foxp3 expression ( Figure 1C) , we tested whether STAT5 or STAT6 interact with DNA methyltransferases Dnmt1 and Dnmt3a, responsible for maintenance and de novo DNA methylation, respectively (Wu and Zhang, 2010) . We found that STAT6, but not STAT5, coprecipitates with Dnmt1 and, to a lesser degree, with Dnmt3a ( Figure 3C ). In agreement with a previous report (Zhang et al., 2005) , we also observed Dnmt1 association with STAT3 (data not shown) and STAT3 binding to the aforementioned STAT5-binding sites in the Foxp3 locus ( Figure S3D ).
We previously reported that, after transient depletion of Treg cells in Foxp3 DTR mice, recovering Treg cells rapidly divide in the presence of high amounts of Th2, Th1, and Th17 cytokines (Arvey et al., 2014; . Under these conditions, we observed sharply increased CpG methylation at the À1.5 kb region and exon-1 in dividing activated Treg cells (Figure 3D) . Furthermore, blockage of Dnmt activity with 5-aza-dC resulted in considerable albeit partial rescue of impaired Foxp3 maintenance by dividing CNS2-deficient Treg cells in the presence of IL-4 in vitro ( Figure 3E ). Together, our data suggest that STAT5 competes with STAT6 for the binding to the Foxp3 locus and prevents silencing of Foxp3 expression by opposing STAT6-mediated recruitment of Dnmt1 to Foxp3 regulatory elements that are partially remethylated during Treg cell division. 
CNS2-Dependent
Foxp3
CNS2fl-gfp mice were activated in vitro with plate-coated CD3 and CD28 antibodies in the presence of IL-2 (500 U/ml) and proinflammatory cytokines. (D) Elevated CpG methylation in the Foxp3 locus in Treg cells expanding under inflammatory conditions in vivo. Activated Treg cells were FACS purified from Foxp3 DTR mice on day 10 after diphtheria toxin injection (see Extended Experimental Procedures). CpG methylation levels were averaged from >5,000 reads in each site of the Foxp3 locus and were compared to control Treg cells and ex vivo isolated exTreg cells (see also Figure S1B ). The data represent two independent experiments. Mean ± SEM. (E) Blockage of Dnmt activity with 5-aza-deoxycytidine (5-aza-dC) partially restores heritable Foxp3 expression in Treg cells exposed to IL-4. Doubly sorted Treg cells from Ly5.1 Foxp3 gfp and Ly5.2 Foxp3 DCNS2-gfp male mice were cocultured with CD3 and CD28 antibody-coated beads for 7 days in the presence of 500 U/ml IL-2 with or without IL-4 or 0.1mM 5-aza-dC. Relative increases in the percentages of Foxp3 + cells and Foxp3 expression (MFI) on a per cell basis were calculated.
Deletion of CNS2 was induced upon treatment with 4-hydroxytamoxifen (4-OHT). Histograms show only the dividing cells (R3 divisions
The data represent one of more than three independent experiments. Mean ± SEM. See also Figure S3 . 
CNS2-Dependent Maintenance of Foxp3 Expression Is Essential for Suppressing Chronic Inflammation
These results suggested that the failure to maintain the Treg cell fate in the absence of CNS2 would result in heightened inflammation and disease in a variety of settings due to a reduced suppressor function of Treg cells and their increased conversion into effector T cells (Figures 5 and S5 ). To test this idea, we evaluated histopathology in aged 12-to 15-month-old Foxp3 DCNS2-gfp mice. We found that CNS2 deficiency resulted in severe inflammatory lesions in numerous nonlymphoid organs, including lung, liver, stomach, and small and large intestine ( Figure 6E and data not shown). In addition, Foxp3 DCNS2-gfp mice exhibited decreased body weight, elevated circulating immunoglobulin (Ig) levels, and activated effector T cells ( Figures 6A-6C ). Thus, CNS2 deficiency results in spontaneous age-dependent inflammatory lesions in nonlymphoid organs. As a consequence of inflammation, CNS2-deficient Treg cell may lose more functional Treg cells due to cell division, proinflammatory cytokine exposure, and/or IL-2 deprivation ( Figures  3A, 2B, and 2C ). To directly test the impact of inflammation on CNS2-deficient Treg stability in vivo without manipulation of Treg cells in vitro, we immunized mixed bone marrow chimeras of Ly5.1 Foxp3 gfp and Ly5.2 Foxp3 DCNS2-gfp mice with MOG peptide and found that, in contrast to CNS2-sufficient Treg cells, CNS2-deficient Treg frequency was remarkably lower in the central nervous system, which was coupled with a dramatically diminished Foxp3 protein level ( Figure 7A ). We also examined the course of MOG peptide-induced EAE in Foxp3
and Foxp3 gfp mice. Although CNS2 deficiency did not impact the onset of the disease or its severity during the initial progressive phase, the disease in Foxp3 DCNS2-gfp mice failed to remit and exhibited a chronic, relentless course after reaching its peak in contrast to the remitting-relapsing disease observed in control Foxp3 gfp mice ( Figures 7B and S6A ). The heightened clinical manifestations, including limb paralysis and weight loss, correlated with a diminished Treg cell frequency among lymphocytes present in the brain and the spinal cord ( Figures S6B-S6D and data not shown). Unlike other nonlymphoid tissues, Treg and effector T cells were barely detectable in the brain and spinal cord of unchallenged control and mutant animals (data not shown). Thus, the more severe, relapse-free disease course is unlikely due to a diminished pre-existing pool of Treg cells in CNS2-deficient mice but is rather a consequence of a loss of Foxp3 expression by CNS2-deficient Treg cells forced into the cell cycle in the setting of a localized chronic autoimmune inflammation (Figures 5 and 7A ).
In addition to spontaneous autoimmune lesions in nonlymphoid organs and autoantigen-driven focal autoimmunity, we explored the role of CNS2-dependent maintenance of Treg cell fate during sterile inflammation associated with obesity. Because metabolic perturbation induced by a high-fat diet (HFD) causes mild chronic inflammation (Feuerer et al., 2009 ), we first investigated Treg cell frequency and effector T cell phenotypes in wild-type Foxp3 gfp and Foxp3 DCNS2-gfp mice that were fed with 60 kcal % high-fat diet (>10 weeks). We found that the frequency of CNS2-sufficient Treg cells was increased in spleen and liver but was decreased in visceral adipose tissue in mice on a HFD. In contrast, the frequency of CNS2-deficient Treg cells was not increased by HFD in comparison to regular diet despite a marked increase in CD25 + cells in CNS2-deficient mice ( Figures 7C, 7D , and S7A-S7C). The failure to increase Treg cell numbers was associated with a dramatic increase in the numbers of activated effector CD44 (Punkosdy et al., 2011) (Figure 7E ), suggesting that CNS2-dependent inheritable maintenance of Treg cells is critical for limiting inflammation during chronic viral infection.
Together, these data demonstrate the crucial role of CNS2-dependent inheritance of Foxp3 expression and highlight a mechanism by which a dedicated cis-element serves to maintain cellular identity during the vulnerable stage of cell division, a prerequisite for Treg cell function during immune homeostasis and acute and chronic inflammation.
DISCUSSION
We found that Treg cell proliferation was a prerequisite for silencing of the Foxp3 locus and that CNS2 opposed the shutdown of Foxp3 expression. Previous studies showed that CNS2 CpGs are methylated in immature Treg cells and are demethylated in mature Treg cells and that a demethylated state of CNS2 was correlated with stable Foxp3 expression (Floess et al., 2007; Polansky et al., 2008; Toker et al., 2013) . Our analysis of stage-specific deletion of CNS2 revealed that its functionality is conditional upon its demethylation in mature Treg cells (data not shown). Thus, demethylated CNS2 opposed Foxp3 silencing in fully differentiated mature Treg cells in an apparently stochastic manner, and the activity of CNS2 was continuously required for the maintenance of heritable Foxp3 expression.
In search of factors that converge on CNS2 to maintain Foxp3 expression during cell division, we uncovered a key role of IL-2-signaling-induced STAT5 activation, which was supported by previous studies of IL-2 signaling in the differentiation and maintenance of Treg cells (Fontenot et al., 2005; Setoguchi et al., 2005) . Our results suggest that, at physiologic levels, IL-2 signaling stabilizes heritable Foxp3 expression in dividing mature Treg cells to a large degree through CNS2. Consistent with this notion and previous work, we found that STAT5 binds to CNS2 and, to a lesser degree, to the Foxp3 promoter (Ogawa et al., 2013; Yao et al., 2007) . Importantly, in the absence of CNS2, STAT5 binding to the Foxp3 promoter was markedly reduced, suggesting that CNS2 may interact with the promoter through a short-distance loop. Consistent with these results, heightened IL-2 signaling or induced expression of STAT5 CA restored stable Foxp3 expression in CNS2-deficient Treg cells. On the other hand, exposure to proinflammatory cytokines, including IL-4, IL-6, and IFNg, resulted in a markedly increased loss of Foxp3 in dividing Treg cells in the absence of CNS2 despite the presence of optimal amounts of IL-2. IL-4-activated STAT6 competes with STAT5 for the binding to similar sites in the Foxp3 locus and counteracts STAT5 activity. Unlike STAT5, STAT6 interacted with Dnmt1; CpG methylation at the Foxp3 locus was increased during Treg cell division and, upon loss of Foxp3 expression, was fully returned to the high methylation state of effector T cells. Of note, IL-6-activated STAT3 also binds to the aforementioned sites within the Foxp3 locus and associates with Dnmt1 (data not shown) (Zhang et al., 2005) . Together, these observations suggest that, in the absence of CNS2, STAT proteins activated downstream of proinflammatory cytokine signaling may effectively compete with STAT5 for binding to the Foxp3 locus and may bring DNA methyltransferases and thereby silence Foxp3 transcription. Our experiments indicate that CNS2 likely increases STAT5 occupancy at the Foxp3 promoter prior to inflammation and hence opposes proinflammatory cytokine-driven silencing of the Foxp3 locus. The sum of the opposing effects of IL-2 and proinflammatory cytokine signaling determines the inheritance of Foxp3 expression and the fate of dividing Treg cells. Although in-depth mechanistic understanding of this phenomenon would require careful quantification of active STAT proteins and their affinities for Foxp3-binding sites in Treg cells, our results suggest that CNS2 skews this balance by recruiting STAT5 to the Foxp3 promoter and enabling Treg cells to withstand diminished IL-2 and heightened inflammatory cytokine signaling. Thereby, CNS2 serves as a critical determinant of Treg cell lineage stability upon cell division in inflammatory environments in which IL-2 amounts are limiting. Under physiological conditions, CNS2 maintains the Treg cell population and thereby prevents spontaneous age-dependent inflammation in nonlymphoid organs. Furthermore, CNS2-dependent maintenance of Foxp3 expression limits the chronic, but not acute, phase of organ-specific autoimmune inflammation and precludes the acquisition of effector functions by Treg cells in response to inflammatory cues. Similarly, compromised inheritance of Foxp3 expression in Treg cells in the absence of CNS2 resulted in diminished health status in the course of chronic viral infection as well as increased immune cell activation during sterile metabolic inflammation.
It seems likely that the observed features of regulation of the inheritance of Treg cell identity upon integration of extracellular cues by a cis-regulatory element dedicated to cell fate maintenance may be operational in other dividing cell types. Susceptibility to a stochastic downregulation of the expression of a lineage specification factor such as Foxp3 and the need for a dedicated regulatory element to oppose such a loss might be linked to the intrinsic inhibition of transcriptional activity, splitting and dilution of transcription factors, and histone modifications during cell division (Gottesfeld and Forbes, 1997; Mullen et al., 2001; Probst et al., 2009 ). Thus, the mitosis-related transcriptional fluctuation could increase the probability of complete transcriptional silencing of Foxp3 expression through yet-to-be defined active or passive processes (Losick and Desplan, 2008) . Considering the respective positive and negative roles of IL-2 and proinflammatory cytokines in the heritable expression of Foxp3, it seems likely that the promotion of cell division by these factors may increase the vulnerability of Treg cells to the loss of their identity due to the stochastic silencing of Foxp3 by molecular mechanisms that remain to be explored.
In conclusion, we found that CNS2, a cis-acting regulatory element dedicated to heritable maintenance of the active state of the Foxp3 locus, enables dividing Treg cells to maintain their differentiated state upon deprivation of their essential growth factor IL-2 and upon exposure to proinflammatory cues driving alternative effector T cell differentiation. CNS2-dependent stability of the Treg cell lineage is critical for preventing spontaneous, age-dependent chronic inflammation in a variety of nonlymphoid organs, for restraining metabolic inflammation associated with diet-induced obesity, and for limiting organ-specific autoimmunity as well as the wasting syndrome during chronic viral infection.
EXPERIMENTAL PROCEDURES
See the Extended Experimental Procedures for further information
Animals
Foxp3
DCNS2-gfp and Foxp3 CNS2fl-gfp mice (Zheng et al., 2010) were backcrossed onto C57BL/6 background for more than ten generations. Foxp3 DTR and Foxp3 gfpko were described previously (Gavin et al., 2007; . R26-Stop fl -STAT5 CA mice were generated by inserting a coding sequence of STAT5 CA and a GFP reporter into the Rosa26 locus (Sasaki et al., 2006) (T.C. and A.Y.R., unpublished results). All animals were maintained in the MSKCC animal facility under SPF conditions, and the experiments were performed according to the institutional guidelines (IACUC 08-10-023).
Generation of Bone Marrow Chimeras and Adoptive T Cell Transfers
For the generation of bone marrow (BM) chimeras, recipient mice were irradiated (9.5 Gy) 24 hr prior to bone marrow stem cell transfer. BM cells were depleted of T cells with Dynabeads FlowComp Mouse Pan T kit (Life Technologies) and were injected i.v. into irradiated recipients. After BM transfer, recipient mice received neomycin with drinking water (2 mg/ml) for 3 weeks and were analyzed 8-12 weeks later. 
Statistical Analysis
For statistical analysis, unpaired two-tailed Student's t test was performed using Prism (GraphPad) or Excel (Microsoft). Regression analysis and plotting were performed with Excel. *p % 0.05, **p % 0.01, ***p % 0.001, and **** p % 0.0001.
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